Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study

Overview

Journal Iran J Psychiatry

Specialty Psychiatry

Date 2018 Jul 13

PMID 29997653

Citations 5

Authors

Alice Caldiroli

Marta Serati

Giulia Orsenigo

Elisabetta Caletti

Massimiliano Buoli

Affiliations

Soon will be listed here.

Abstract

Purposes of the present study were to assess the social cognitive impairment in schizophrenia and to detect if some clinical variables (particularly age at onset) are predictive of general/social cognitive deficit in schizophrenia patients. Thirty-five clinically stabilized schizophrenia outpatients were assessed by the Brief Assessment of Cognition in Schizophrenia (BACS) and by Torralva's social cognition battery. Binary logistic models were performed to find an eventual association between continuous clinical variables and cognitive test failures. The total sample was divided in groups according to dichotomous variables (gender, diagnostic subtypes and type of abuse) and the presence of cognitive deficits was compared between groups by χ2 tests. An earlier age at onset was found to be predictive of frontal cognitive impairment (Tower of London p=0.038, OR=0.702). Female gender was more probably associated with mistakes at MET-HV (χ2= 4.80, p=0.05, phi=0.40) and HOTEL tests (χ2= 5.25, p=0.04, phi=0.4) than male one. Cannabis abusers showed more frequently deficits on verbal fluency (χ2= 9.35, p=0.04, phi=0.52) and executive functioning (Tower of London) (χ2= 11.67, p=0.02, phi=0.58) than alcohol/cocaine ones. Female patients with an early age at onset and cannabis abuse seem to have the worst general and social cognitive profile among patients suffering from schizophrenia.

Citing Articles

Gender differences in clinical and biochemical parameters among patients hospitalized for schizophrenia: towards precision medicine.

Esposito C, De Cagna F, Caldiroli A, Capuzzi E, Ceresa A, Di Paolo M Eur Arch Psychiatry Clin Neurosci. 2023; 274(5):1093-1103.

PMID: 37436457 PMC: 11229447. DOI: 10.1007/s00406-023-01644-4.

Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia.

Li J, Li D, Guo J, Wang D, Zhang X Antioxidants (Basel). 2023; 12(6).

PMID: 37371989 PMC: 10295646. DOI: 10.3390/antiox12061259.

Are Executive Functions Deficits in Early-Onset Chronic Schizophrenia More Severe than in Adult-Onset Chronic Schizophrenia?.

Hintze B, Rowicka M, Barczak A Clin Neuropsychiatry. 2022; 19(1):54-63.

PMID: 35360466 PMC: 8951167. DOI: 10.36131/cnfioritieditore20220108.

The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study.

Caldiroli A, Capuzzi E, Tringali A, Tagliabue I, Turco M, Fortunato A Psychiatry Res. 2021; 307:114334.

PMID: 34902818 PMC: 8664498. DOI: 10.1016/j.psychres.2021.114334.

Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?.

Morelli V, Ghielmetti A, Caldiroli A, Grassi S, Siri F, Caletti E J Clin Endocrinol Metab. 2020; 106(1):e130-e139.

PMID: 33017843 PMC: 7765655. DOI: 10.1210/clinem/dgaa695.

References

Buoli M, Caldiroli A, Panza G, Altamura A . Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study. Psychiatry Investig. 2012; 9(4):354-60. PMC: 3521111. DOI: 10.4306/pi.2012.9.4.354. View

Addington D, Addington J, Schissel B . A depression rating scale for schizophrenics. Schizophr Res. 1990; 3(4):247-51. DOI: 10.1016/0920-9964(90)90005-r. View

Ringen P, Vaskinn A, Sundet K, Engh J, Jonsdottir H, Simonsen C . Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med. 2009; 40(8):1337-47. DOI: 10.1017/S0033291709991620. View

Bellack A, Sayers M, Mueser K, Bennett M . Evaluation of social problem solving in schizophrenia. J Abnorm Psychol. 1994; 103(2):371-8. DOI: 10.1037//0021-843x.103.2.371. View

Endicott J, Spitzer R, Fleiss J, Cohen J . The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976; 33(6):766-71. DOI: 10.1001/archpsyc.1976.01770060086012. View

Amminger G, Edwards J, Brewer W, Harrigan S, McGorry P . Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr Res. 2002; 54(3):223-30. DOI: 10.1016/s0920-9964(01)00278-x. View

Schaefer J, Giangrande E, Weinberger D, Dickinson D . The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res. 2013; 150(1):42-50. PMC: 4196267. DOI: 10.1016/j.schres.2013.07.009. View

Palmer B, Dawes S, Heaton R . What do we know about neuropsychological aspects of schizophrenia?. Neuropsychol Rev. 2009; 19(3):365-84. PMC: 2745531. DOI: 10.1007/s11065-009-9109-y. View

Barch D, Keefe R . Anticipating DSM-V: opportunities and challenges for cognition and psychosis. Schizophr Bull. 2009; 36(1):43-7. PMC: 2800153. DOI: 10.1093/schbul/sbp139. View

10.

Bergh S, Hjorthoj C, Sorensen H, Fagerlund B, Austin S, Secher R . Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study. Schizophr Res. 2016; 175(1-3):57-63. DOI: 10.1016/j.schres.2016.03.025. View

11.

Peer J, Bennett M, Bellack A . Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups. J Nerv Ment Dis. 2009; 197(8):631-4. PMC: 2777610. DOI: 10.1097/NMD.0b013e3181b08bf4. View

12.

Kravariti E, Morris R, Rabe-Hesketh S, Murray R, Frangou S . The Maudsley Early-Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia. Schizophr Res. 2003; 65(2-3):95-103. DOI: 10.1016/s0920-9964(03)00067-7. View

13.

Lappin J, Morgan K, Morgan C, Dazzan P, Reichenberg A, Zanelli J . Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr Res. 2007; 95(1-3):103-10. DOI: 10.1016/j.schres.2007.05.037. View

14.

Dillon C, Taragano F, Sarasola D, Iturry M, Serrano C, Raczkowski A . [Cognitive performance in schizophrenia (paranoid vs residual subtype)]. Vertex. 2007; 18(73):170-5. View

15.

San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I . Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry. 2007; 22(8):490-8. DOI: 10.1016/j.eurpsy.2007.06.005. View

16.

Manly T, Hawkins K, Evans J, Woldt K, Robertson I . Rehabilitation of executive function: facilitation of effective goal management on complex tasks using periodic auditory alerts. Neuropsychologia. 2001; 40(3):271-81. DOI: 10.1016/s0028-3932(01)00094-x. View

17.

Liu S, Hsieh M, Huang T, Liu C, Liu C, Hua M . Patterns and clinical correlates of neuropsychologic deficits in patients with schizophrenia. J Formos Med Assoc. 2006; 105(12):978-91. DOI: 10.1016/S0929-6646(09)60282-5. View

18.

Remschmidt H, Theisen F . Early-onset schizophrenia. Neuropsychobiology. 2012; 66(1):63-9. DOI: 10.1159/000338548. View

19.

Keefe R, Goldberg T, Harvey P, Gold J, Poe M, Coughenour L . The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004; 68(2-3):283-97. DOI: 10.1016/j.schres.2003.09.011. View

20.

Puig O, Penades R, Baeza I, Sanchez-Gistau V, De la Serna E, Fonrodona L . Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia. Eur Child Adolesc Psychiatry. 2012; 21(6):315-26. DOI: 10.1007/s00787-012-0262-0. View